SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-007371
Filing Date
2024-10-24
Accepted
2024-10-24 17:27:53
Documents
20
Period of Report
2024-10-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cns_8k.htm   iXBRL 8-K 38890
2 PLACEMENT AGENCY AGREEMENT DATED OCTOBER 23, 2024, BETWEEN CNS PHARMACEUTICALS, cns_ex0101.htm EX-1.1 50836
3 FORM OF PRE-FUNDED WARRANT cns_ex0401.htm EX-4.1 100020
4 ARENTFOX SCHIFF LLP LEGAL OPINION cns_ex0501.htm EX-5.1 16326
5 FORM OF SECURITIES PURCHASE AGREEMENT cns_ex1001.htm EX-10.1 253043
6 PRESS RELEASE DATED OCTOBER 23, 2024 cns_ex9901.htm EX-99.1 11476
10 GRAPHIC image_001.jpg GRAPHIC 8980
11 GRAPHIC image_002.jpg GRAPHIC 6356
  Complete submission text file 0001683168-24-007371.txt   776573

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE cnsp-20241023.xsd EX-101.SCH 3018
8 XBRL LABEL FILE cnsp-20241023_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE cnsp-20241023_pre.xml EX-101.PRE 22361
22 EXTRACTED XBRL INSTANCE DOCUMENT cns_8k_htm.xml XML 3802
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39126 | Film No.: 241393567
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)